Leflunomide for childhood idiopathic lung bleeding
Treatments studied
Part of Hormones & metabolism, Lungs & breathing clinical trials.
This trial tests whether leflunomide can safely help children with idiopathic pulmonary hemosiderosis (a condition where the lungs bleed, and iron builds up). The study is mainly about safety and early signs of benefit in young patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 6 months and 18 years old
- Your child has been diagnosed with idiopathic pulmonary hemosiderosis
- A parent or legal guardian can agree to treatment and sign consent
- Your child is not allergic to any ingredient in leflunomide tablets
- Your child does not have serious problems with organs or immune system (like liver/kidney failure, immune deficiency, severe infections, or heart failure)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether leflunomide can calm Henoch-Schonlein purpura (a childhood rash condition) when the rash is hard to control. If standard treatments don’t stop new or worsening rash, this study may offer another option.
This early-phase trial tests whether adding leflunomide to standard steroid treatment can better control acute graft-versus-host disease (aGvHD) after a stem cell transplant. It may help reduce the immune reaction that damages the body while keeping treatment safe and manageable.
This study looks at how your genes might affect how well leflunomide works for rheumatoid arthritis. It is for Pakistani adults who are starting or recently started leflunomide, and will help doctors understand who might respond best.
This trial tests if adding teriflunomide to high-dose dexamethasone helps adults newly diagnosed with immune thrombocytopenia (ITP) who have low platelets or bleeding. It aims to find a safer, more effective way to raise platelet counts.
This study tests anifrolumab, a new injection medicine that may help control systemic lupus erythematosus (SLE) in children and teens. Researchers will measure how the body processes the medicine and whether it helps reduce lupus activity while monitoring for side effects.
This study tests whether the drug leflunomide can prevent CMV virus reactivation after a half-matched stem cell transplant. If you have already had a successful white blood cell recovery and no sign of CMV, this might help keep you safe from the virus.
Hear when a new Idiopathic Pulmonary Hemosiderosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.